Sunshine Lake Pharma Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	1,487	1,404	1,674	923.54	1,131
Trading Asset Securities	15.83	3.84	-	290	-
Cash & Short-Term Investments	1,503	1,408	1,674	1,214	1,131
Cash Growth	6.75%	-15.93%	37.98%	7.29%	-44.69%
Accounts Receivable	1,733	2,104	2,073	1,006	479.04
Other Receivables	158.99	153.65	40.19	31.1	67.75
Receivables	1,892	2,257	2,113	1,037	546.79
Inventory	783.49	645.93	409.05	315.03	279.7
Restricted Cash	25.5	395.61	1,567	76.78	91.99
Other Current Assets	446.65	326.91	289.5	2,372	7.78
Total Current Assets	4,651	5,033	6,053	5,014	2,057
Property, Plant & Equipment	4,310	3,964	3,740	3,519	3,217
Long-Term Investments	26.01	42.53	32.16	-	1,790
Goodwill	-	-	-	-	75.9
Other Intangible Assets	791.69	2,504	2,566	2,921	2,071
Long-Term Deferred Tax Assets	278	236.01	237.69	140.61	65.32
Long-Term Deferred Charges	691.33	-	-	-	1,201
Other Long-Term Assets	1,245	650.08	115.38	295.76	64.83
Total Assets	11,993	12,429	12,744	11,890	10,542
Accounts Payable	1,032	192.55	200.52	178.61	193.47
Accrued Expenses	1,326	774.67	1,397	1,342	480.34
Current Portion of Long-Term Debt	2,785	1,174	2,165	3,055	48.48
Current Portion of Leases	460.25	161.32	154.44	75.44	-
Current Income Taxes Payable	43.94	0.23	146.21	8.67	198.63
Current Unearned Revenue	152.22	37.63	109.64	83.58	79.28
Other Current Liabilities	238.28	500.43	158.48	197.86	237.87
Total Current Liabilities	6,038	2,841	4,332	4,941	1,238
Long-Term Debt	1,278	747.27	254	629.03	3,145
Long-Term Leases	157.39	152.54	35.45	62.5	-
Long-Term Unearned Revenue	181.98	180.68	187.15	187.49	137.73
Other Long-Term Liabilities	0	-	-	-	-
Total Liabilities	7,655	3,921	4,809	5,820	4,521
Common Stock	576.66	879.97	879.97	879.97	879.97
Retained Earnings	-644.48	4,870	4,387	2,395	2,318
Treasury Stock	-23.39	-	-	-	-
Comprehensive Income & Other	4,436	2,758	2,668	2,610	2,610
Total Common Equity	4,345	8,508	7,936	5,885	5,808
Minority Interest	-6.56	-	-	185.12	212.48
Shareholders' Equity	4,338	8,508	7,936	6,070	6,021
Total Liabilities & Equity	11,993	12,429	12,744	11,890	10,542
Total Debt	4,680	2,235	2,609	3,822	3,194
Net Cash (Debt)	-3,177	-827.22	-934.92	-2,608	-2,062
Net Cash Per Share	-6.38	-3.57	-4.03	-11.24	-8.89
Filing Date Shares Outstanding	576.66	879.97	879.97	879.97	879.97
Total Common Shares Outstanding	576.66	879.97	879.97	879.97	879.97
Working Capital	-1,387	2,193	1,721	73.24	819.31
Book Value Per Share	7.53	9.67	9.02	6.69	6.60
Tangible Book Value	3,553	6,005	5,370	2,964	3,662
Tangible Book Value Per Share	6.16	6.82	6.10	3.37	4.16
Machinery	4,798	3,660	3,448	3,021	2,680
Construction In Progress	615.67	826.56	638.2	675.45	567.94

Source: S&P Global Market Intelligence. Standard template. Financial Sources.